机译:一项针对呼吸道合胞病毒的基于RNAi的疗法的随机,双盲,安慰剂对照研究
Departments of Pediatrics and Molecular Sciences, University of Tennessee School of Medicine and The Children's Foundation Research Center, Memphis,TN 38103;
Retroscreen Virology Ltd., Centre for Infectious Diseases, Queen Mary University of London, London E1 4NS, United Kingdom;
Southampton University School of Medicine, Division of Infection, Inflammation, and Immunity, Southampton General Hospital, Southampton SO16 6YD, United Kingdom;
Alnylam Pharmaceuticals, Inc., Cambridge, MA 02142;
Alnylam Pharmaceuticals, Inc., Cambridge, MA 02142;
University of Rochester School of Medicine and Dentistry, Infectious Diseases Unit, Rochester General Hospital, Rochester, NY 14621;
Alnylam Pharmaceuticals, Inc., Cambridge, MA 02142;
Alnylam Pharmaceuticals, Inc., Cambridge, MA 02142;
Alnylam Pharmaceuticals, Inc., Cambridge, MA 02142;
antiviral; RNA interference; small interfering RNA; RSV;
机译:JNJ-53718678的人口药代动力学建模,一种用于治疗呼吸道合胞病毒的新型融合剂:I阶段I,双盲,随机,安慰剂控制的健康成年对象的一对人类研究
机译:MAKI试验的伦理学考虑和依据:多中心双盲随机安慰剂对照试验,研究帕利珠单抗对胎龄为33-35周的儿童呼吸道合胞病毒感染相关的反复喘息的预防作用
机译:地塞米松治疗严重呼吸道合胞病毒(RSV)感染的随机,双盲,安慰剂对照试验:对RSV数量和临床结局的影响。
机译:靶向脉冲电磁场治疗对犬术后血栓切除术的影响:双盲,随机,安慰剂对照临床试验
机译:一项随机,双盲,安慰剂对照的临床试验,评估英夫利昔单抗对I / II型双相情感障碍抑郁症患者总体认知的影响
机译:一项针对呼吸道合胞病毒的基于RNAi的疗法的随机双盲安慰剂对照研究
机译:一项针对呼吸道合胞病毒的基于RNAi的疗法的随机,双盲,安慰剂对照研究